374 related articles for article (PubMed ID: 10448130)
1. The potential of melanoma antigen expression in cancer therapy.
Gillespie AM; Coleman RE
Cancer Treat Rev; 1999 Aug; 25(4):219-27. PubMed ID: 10448130
[TBL] [Abstract][Full Text] [Related]
2. [Melanoma antigen genes(MAGE) and malignant tumors].
Xu JZ; Lin S
Ai Zheng; 2003 Sep; 22(9):1001-4. PubMed ID: 12969539
[TBL] [Abstract][Full Text] [Related]
3. The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptides.
Zhang XM; Zhang YF; Huang Y; Qu P; Ma B; Si SY; Li ZS; Li WX; Li X; Ge W; Hu PZ; Sui YF
Oncol Rep; 2008 Jul; 20(1):245-52. PubMed ID: 18575744
[TBL] [Abstract][Full Text] [Related]
4. [Tumor antigens recognized by T-lymphocytes in human cancers. New advances and therapeutic perspectives].
Gaugler B; Olive D
Pathol Biol (Paris); 1998 Dec; 46(10):771-8. PubMed ID: 9922993
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.
Nishiyama T; Tachibana M; Horiguchi Y; Nakamura K; Ikeda Y; Takesako K; Murai M
Clin Cancer Res; 2001 Jan; 7(1):23-31. PubMed ID: 11205913
[TBL] [Abstract][Full Text] [Related]
6. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
[TBL] [Abstract][Full Text] [Related]
7. [Rejection antigens of tumors and specific immunotherapy of cancer].
Boon T; Lucas S
Bull Mem Acad R Med Belg; 1996; 151(12):469-79. PubMed ID: 9491625
[TBL] [Abstract][Full Text] [Related]
8. Melanoma-associated antigen genes - an update.
Sang M; Wang L; Ding C; Zhou X; Wang B; Wang L; Lian Y; Shan B
Cancer Lett; 2011 Mar; 302(2):85-90. PubMed ID: 21093980
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-associated tumor antigens and their clinical relevance to immunotherapy.
Gattoni-Celli S; Cole DJ
Semin Oncol; 1996 Dec; 23(6):754-8. PubMed ID: 8970598
[TBL] [Abstract][Full Text] [Related]
10. Melanoma vaccine candidates from chimeric hepatitis B core virus-like particles carrying a tumor-associated MAGE-3 epitope.
Kazaks A; Balmaks R; Voronkova T; Ose V; Pumpens P
Biotechnol J; 2008 Nov; 3(11):1429-36. PubMed ID: 18956370
[TBL] [Abstract][Full Text] [Related]
11. MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma.
Gibbs P; Hutchins AM; Dorian KT; Vaughan HA; Davis ID; Silvapulle M; Cebon JS
Melanoma Res; 2000 Jun; 10(3):259-64. PubMed ID: 10890380
[TBL] [Abstract][Full Text] [Related]
12. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter: implications for MAGE immunotherapy.
Oaks MK; Hanson JP; O'Malley DP
Cancer Res; 1994 Apr; 54(7):1627-9. PubMed ID: 8137270
[TBL] [Abstract][Full Text] [Related]
14. The melanoma antigen genes--any clues to their functions in normal tissues?
Ohman Forslund K; Nordqvist K
Exp Cell Res; 2001 May; 265(2):185-94. PubMed ID: 11302683
[TBL] [Abstract][Full Text] [Related]
15. High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene.
Hillig RC; Coulie PG; Stroobant V; Saenger W; Ziegler A; Hülsmeyer M
J Mol Biol; 2001 Jul; 310(5):1167-76. PubMed ID: 11502003
[TBL] [Abstract][Full Text] [Related]
16. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
[No Abstract] [Full Text] [Related]
17. Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy.
Ries J; Schultze-Mosgau S; Neukam F; Diebel E; Wiltfang J
Int J Oncol; 2005 Mar; 26(3):817-24. PubMed ID: 15703841
[TBL] [Abstract][Full Text] [Related]
18. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.
Dannull J; Diener PA; Prikler L; Fürstenberger G; Cerny T; Schmid U; Ackermann DK; Groettrup M
Cancer Res; 2000 Oct; 60(19):5522-8. PubMed ID: 11034097
[TBL] [Abstract][Full Text] [Related]
19. The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.
François V; Ottaviani S; Renkvist N; Stockis J; Schuler G; Thielemans K; Colau D; Marchand M; Boon T; Lucas S; van der Bruggen P
Cancer Res; 2009 May; 69(10):4335-45. PubMed ID: 19435913
[TBL] [Abstract][Full Text] [Related]
20. A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells.
Zhang Y; Renkvist N; Sun Z; Schuler-Thurner B; Glaichenhaus N; Schuler G; Boon T; van der Bruggen P; Colau D
Eur J Immunol; 2005 Apr; 35(4):1066-75. PubMed ID: 15756643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
